6.7.1. Definition of CRPC. Castrate serum testosterone < 50 ng/dL or 1.7 nmol/L plus either: a.Biochemical progression: Three consecutive rises in PSA at least one week apart resulting in two 50% increases over the nadir, and a PSA > 2 ng/mL or b.Radiological progression: The appearance of new lesions: either two or more new bone lesions on bone scan or a soft tissue lesion using RECIST (Response Evaluation Criteria in Solid Tumours) [1156]. Symptomatic progression alone must be questioned and subject to further investigation. It is not sufficient to diagnose CRPC. 